Teza Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,923
Closed -$421K 112
2025
Q4
$421K Buy
+16,923
New +$427K 1.36% 25
2025
Q3
Sell
-15,405
Closed -$373K 245
2025
Q2
$373K Sell
15,405
-44,869
-74% -$1.05M 0.28% 142
2025
Q1
$1.53M Sell
60,274
-88,892
-60% -$2.33M 0.7% 14
2024
Q4
$3.96M Buy
149,166
+137,293
+1,156% +$3.72M 0.6% 28
2024
Q3
$344K Sell
11,873
-19,288
-62% -$563K 0.04% 456
2024
Q2
$872K Buy
+31,161
New +$858K 0.11% 270
2024
Q1
Sell
-14,615
Closed -$421K 703
2023
Q4
$421K Buy
+14,615
New +$442K 0.07% 331
2023
Q2
Sell
-53,001
Closed -$2.16M 689
2023
Q1
$2.16M Buy
+53,001
New +$2.29M 0.47% 46
2022
Q4
Sell
-39,860
Closed -$1.74M 697
2022
Q3
$1.74M Buy
+39,860
New +$1.94M 0.36% 69
2022
Q1
Sell
-6,723
Closed -$397K 502
2021
Q4
$397K Sell
6,723
-20,345
-75% -$1.01M 0.11% 262
2021
Q3
$1.16M Buy
27,068
+17,142
+173% +$759K 0.56% 45
2021
Q2
$389K Sell
9,926
-89,138
-90% -$3.47M 0.06% 376
2021
Q1
$3.59M Buy
+99,064
New +$3.52M 0.72% 27
2020
Q3
Sell
-48,975
Closed -$1.52M 549
2020
Q2
$1.52M Buy
+48,975
New +$1.66M 0.34% 75
2019
Q4
Sell
-40,941
Closed -$1.4M 687
2019
Q3
$1.4M Buy
+40,941
New +$1.49M 0.36% 78
2018
Q2
Sell
-17,481
Closed -$589K 553
2018
Q1
$589K Buy
+17,481
New +$601K 0.14% 267
2017
Q2
Sell
-78,154
Closed -$2.54M 273
2017
Q1
$2.54M Buy
+78,154
New +$2.46M 0.74% 17

Other funds holding PFE

Teza Capital Management's PFE Position: Q1 2026 in Review

Teza Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 16,923 shares — an estimated $421K sold.

Teza Capital Management first reported a position in PFE in Q1 2017 and held it in 17 quarters. The position peaked at $3.96M in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Teza Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Teza Capital Management sold 16,923 Pfizer shares in Q1 2026, an estimated $421K.
  • Teza Capital Management first reported a position in Pfizer in Q1 2017 and held it in 17 quarters.
  • Teza Capital Management's Pfizer position peaked at $3.96M in Q4 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Teza Capital Management's 13F filing for Q1 2026, filed 15 May 2026.